114 related articles for article (PubMed ID: 38914966)
1. The association between abcb1 gene polymorphism and clopidogrel response variability in stroke ischemic: a cross sectional study.
Hidayat R; Nabilah RA; Fisher M; Aninditha T; Kurniawan M; Estiasari R; Indrawati LA; Safri AY; Mesiano T; Rasyid A; Harris S
BMC Neurol; 2024 Jun; 24(1):216. PubMed ID: 38914966
[TBL] [Abstract][Full Text] [Related]
2. Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial.
Pan Y; Chen W; Wang Y; Li H; Johnston SC; Simon T; Zhao X; Liu L; Wang D; Meng X; Wang Y;
JAMA Neurol; 2019 May; 76(5):552-560. PubMed ID: 30742211
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis.
Mega JL; Close SL; Wiviott SD; Shen L; Walker JR; Simon T; Antman EM; Braunwald E; Sabatine MS
Lancet; 2010 Oct; 376(9749):1312-9. PubMed ID: 20801494
[TBL] [Abstract][Full Text] [Related]
4. Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study.
Kim IS; Jeong YH; Park Y; Yoon SE; Kwon TJ; Park JR; Hwang SJ; Koh EH; Kwak CH; Hwang JY; Kim S
Br J Clin Pharmacol; 2012 Apr; 73(4):629-40. PubMed ID: 22007612
[TBL] [Abstract][Full Text] [Related]
5. ABCB1 hypomethylation is associated with decreased antiplatelet effects of clopidogrel in Chinese ischemic stroke patients.
Yang J; Zhou JS; Zhao YX; Yang ZH; Zhao HD; Zhang YD; Zou JJ
Pharmazie; 2015 Feb; 70(2):97-102. PubMed ID: 25997249
[TBL] [Abstract][Full Text] [Related]
6. Effect of the CYP2C19 2 and 3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention.
Tang XF; Wang J; Zhang JH; Meng XM; Xu B; Qiao SB; Wu YJ; Chen J; Wu Y; Chen JL; Gao RL; Yuan JQ; Yang YJ
Eur J Clin Pharmacol; 2013 May; 69(5):1103-12. PubMed ID: 23150151
[TBL] [Abstract][Full Text] [Related]
7. No association of ABCB1 C3435T genotype with clopidogrel response or risk of stent thrombosis in patients undergoing coronary stenting.
Jaitner J; Morath T; Byrne RA; Braun S; Gebhard D; Bernlochner I; Schulz S; Mehilli J; Schömig A; Koch W; Kastrati A; Sibbing D
Circ Cardiovasc Interv; 2012 Feb; 5(1):82-8, S1-2. PubMed ID: 22298798
[TBL] [Abstract][Full Text] [Related]
8. Combined influence of ABCB1 genetic polymorphism and DNA methylation on aspirin resistance in Chinese ischemic stroke patients.
Xu L; Wang Y
Acta Neurol Belg; 2022 Aug; 122(4):1057-1064. PubMed ID: 34089489
[TBL] [Abstract][Full Text] [Related]
9. Influence of CYP450 Enzymes, CES1, PON1, ABCB1, and P2RY12 Polymorphisms on Clopidogrel Response in Patients Subjected to a Percutaneous Neurointervention.
Saiz-Rodríguez M; Belmonte C; Caniego JL; Koller D; Zubiaur P; Bárcena E; Romero-Palacián D; Eugene AR; Ochoa D; Abad-Santos F
Clin Ther; 2019 Jun; 41(6):1199-1212.e2. PubMed ID: 31128980
[TBL] [Abstract][Full Text] [Related]
10. Effects of the
Biswas M; Rahaman S; Biswas TK; Ibrahim B
Expert Opin Drug Saf; 2020 Dec; 19(12):1605-1616. PubMed ID: 33040624
[TBL] [Abstract][Full Text] [Related]
11. Associations of MDR1, TBXA2R, PLA2G7, and PEAR1 genetic polymorphisms with the platelet activity in Chinese ischemic stroke patients receiving aspirin therapy.
Peng LL; Zhao YQ; Zhou ZY; Jin J; Zhao M; Chen XM; Chen LY; Cai YF; Li JL; Huang M
Acta Pharmacol Sin; 2016 Nov; 37(11):1442-1448. PubMed ID: 27641736
[TBL] [Abstract][Full Text] [Related]
12. Distribution of polymorphisms in the CYP2C19 and ABCB1 genes among patients with acute coronary syndrome in Lower Silesian population.
Wójcik T; Szymkiewicz P; Wiśniewski J; Lebioda A; Jonkisz A; Gamian A; Kuliczkowski W; Ściborski K; Mysiak A; Protasiewicz M
Adv Clin Exp Med; 2019 Dec; 28(12):1621-1626. PubMed ID: 31778598
[TBL] [Abstract][Full Text] [Related]
13.
Santos M; Lima L; Carvalho S; Brandão A; Barroso F; Cruz A; Medeiros R
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791151
[TBL] [Abstract][Full Text] [Related]
14. Clustering of ABCB1 and CYP2C19 Genetic Variants Predicts Risk of Major Bleeding and Thrombotic Events in Elderly Patients with Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel.
Galeazzi R; Olivieri F; Spazzafumo L; Rose G; Montesanto A; Giovagnetti S; Cecchini S; Malatesta G; Di Pillo R; Antonicelli R
Drugs Aging; 2018 Jul; 35(7):649-656. PubMed ID: 29936693
[TBL] [Abstract][Full Text] [Related]
15. Genetic determinants of high on-treatment platelet reactivity in clopidogrel treated Chinese patients.
Zhang L; Chen Y; Jin Y; Qu F; Li J; Ma C; Yang J; Xu B; Wang H; Li X; Li Y; Zhang Y; Lu C; Yin T
Thromb Res; 2013 Jul; 132(1):81-7. PubMed ID: 23726091
[TBL] [Abstract][Full Text] [Related]
16. Clopidogrel responder status is uninfluenced by CYP2C19*2 in Danish patients with stroke.
Rath CL; Jørgensen NR; Wienecke T
PLoS One; 2020; 15(12):e0236260. PubMed ID: 33370281
[TBL] [Abstract][Full Text] [Related]
17. Association between CYP2C19 and ABCB1 polymorphisms and clopidogrel resistance in clopidogrel-treated Chinese patients.
Zhuo ZL; Xian HP; Long Y; Liu C; Sun YY; Ma YT; Gao H; Zhao JZ; Zhao XT
Anatol J Cardiol; 2018 Feb; 19(2):123-129. PubMed ID: 29350207
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of effects of ABCB1 polymorphisms on clopidogrel response among patients with coronary artery disease.
Zhai Y; He H; Ma X; Xie J; Meng T; Dong Y; Lu J
Eur J Clin Pharmacol; 2017 Jul; 73(7):843-854. PubMed ID: 28378058
[TBL] [Abstract][Full Text] [Related]
19. Influence of ABCB1 C3435T and C1236T gene polymorphisms on tumour response to docetaxel-based neo-adjuvant chemotherapy in locally advanced breast cancer patients of South India.
Priyadarshini R; Raj GM; Kayal S; Ramesh A; Shewade DG
J Clin Pharm Ther; 2019 Apr; 44(2):188-196. PubMed ID: 30637776
[TBL] [Abstract][Full Text] [Related]
20. Impact of genetic variants of selected cytochrome P450 isoenzymes on pharmacokinetics and pharmacodynamics of clopidogrel in patients co-treated with atorvastatin or rosuvastatin.
Karaźniewicz-Łada M; Krzyżańska D; Danielak D; Rzeźniczak J; Główka F; Słomczyński M; Burchardt P
Eur J Clin Pharmacol; 2020 Mar; 76(3):419-430. PubMed ID: 31897532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
